- New diagnostics solutions will be presented that help clinicians improve patient care and support healthcare systems.
- Participants can join virtually or onsite to learn about timely healthcare topics related to value-based healthcare, digital health and diagnostic technologies.
- Study results from an evaluation of the newly launched AVENIO Tumour Tissue Comprehensive Genomic Profiling Kit for oncology research will be presented.
- For the first time internationally, GenMark, a subsidiary within the Roche Diagnostics division, will showcase the ePlex® System portfolio.
Rotkreuz, 5 April 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it will be showcasing next generation diagnostics solutions that will deliver fast and accurate results to help clinicians improve patient care and help reduce the healthcare burden at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines (EuroMedLab) in Munich, Germany (rescheduled dates 10 - 14 April 2022). These include the cobas® 5800 System that expands access to PCR testing with meaningful and timely results to more patients across the globe, and a new handheld glucose management device, the cobas® pulse, powered by the cobas® infinity edge suite, that equips healthcare professionals with expanded digital capabilities at the point of care.
An evaluation of the recently launched AVENIO Tumour Tissue Comprehensive Genomic Profiling (CGP) Kit for oncology research will be presented. The kit helps expand access to genomic profiling globally, supporting researchers in navigating the complex landscape of cancer research. The findings assess genomic results generated across multiple CGP workflows for variants that are known to cause and drive cancer.
Roche is committed to developing innovative solutions that equip healthcare professionals with the tools that allow for earlier diagnosis and more personalised treatment, optimising patient care and leading to better outcomes,
said Ann Costello, Global Head, Roche Diagnostics Solutions.
We are proud to work in partnership with healthcare professionals across many disease areas and disciplines to enable better healthcare decisions.
Roche will also host its very own highly interactive booth, where attendees can visit and experience how Roche is helping to improve healthcare. Highlights from the booth include an integrated diagnostics lab and data analytics tools that guide the decision-making process toward optimising lab operations, customer delivery, and overall lab performance in a targeted and efficient manner. There will also be a special interactive area at the booth highlighting Roche’s COVID-19 response.
Lab medicine has always played a key role in healthcare, as proven during the Covid-19 pandemic,
emphasised Moritz Hartmann, Global Head of Roche Information Solutions.
We are working with industry leaders worldwide on digital health solutions to facilitate data-driven decision-making in any setting. This includes labs, clinics and homes with the ultimate goal to improve care for each patient and reduce inefficiencies in healthcare delivery.
Those unable to attend the congress in person will be able to view and engage in the virtual booth via an online portal, with Ro_Bot, a virtual character, as host: Roche EuroMedLab 2021. Those joining online will be able to follow key sessions via livestream, at no cost.
During the congress, Roche will facilitate discussions on the key topics in diagnostics today, including three educational workshops:
Monday 11 April, 14:00–15:00
EduW5: Pandemic Preparedness
Chair: Dr. Christian Simon, Roche Diagnostics
Fighting emerging pathogens – the COVID pandemic response in Germany
Professor Dr Andreas Weiser, Global Health & Infectious Diseases, at the Medical Center of the University of Munich
Diagnostic follow-up in a post vaccine setting
Professor Dr. Stefan Holdenrieder, Director of the Institute of Laboratory Medicine, German Heart Center of the Technical University Munich
Tuesday 12 April, 14:00-15:00
EduW19: Diagnostic Innovation Drivers
Chair: Dr. Wim van der Helm, Roche Diagnostics
Use of mass spectrometry in clinical diagnostics
Professor Dr. Michael Vogeser, Germany
Timely and accurate differential diagnosis of patients with cognitive impairment
Professor Dr. Charlotte Teunissen, University Medische, Centra Amsterdam
Wednesday 13 April, 14:00-15:00
EduW33: Diabetes and the heart
Chair: Dr, Paul van Haelst, Roche Diabetes Care
Early identification of heart failure in T2D: intervention for improving patient outcomes
Dr. Muthiah Veduganathan, MD. MPH, Harvard Medical School, Boston, USA
Integrated personal diabetes management
Professor Dr. Stephan Jacob, Praxis Für Prävention und Therapie, Villingen-Schwenningen, Germany